US 9926369
Methods for treating hepatocellular cancer by administering an anti-Ang-2 antibody
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 9926369 (Methods for treating hepatocellular cancer by administering an anti-Ang-2 antibody) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K31/513, A61K38/1866